The dynamic changes in the levels of neutralizing antibodies to live SARS-CoV-2, levels of anti-SARS-CoV-2 IgG and IgM, and the inhibition rates of neutralizing antibodies to pseudovirus demonstrate that the induced antibody levels did not significantly increase until after the second dose of COVID-19 vaccine. The gene discussed is CD40LG; the disease is COVID-19.